|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| C07D 473/00 | |||
| C07D 487/04 | |||
| A61P 29/00 |
| (11) | Number of the document | 2175859 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08781709.4 |
| Date of filing the European patent application | 2008-07-11 | |
| (97) | Date of publication of the European application | 2010-04-21 |
| (45) | Date of publication and mention of the grant of the patent | 2012-03-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/069813 |
| Date | 2008-07-11 |
| (87) | Number | WO 2009/009740 |
| Date | 2009-01-15 |
| (30) | Number | Date | Country code |
| 949328 P | 2007-07-12 | US |
| (72) |
KRASINSKI, Antoni, US
PUNNA, Sreenivas, US
UNGASHE, Solomon, US
WANG, Qiang, US
ZENG, Yibin, US
|
| (73) |
ChemoCentryx, Inc.,
850 Maude Avenue, Mountain View California 94043,
US
|
| (54) | FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION |
| FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION |